1-866-598-7166

Stereotactic Radiotherapy for Metastatic Kidney Cancer Being Treated With Sunitinib (OZM-053 Study)

Trial ID: NCT02019576
Kidney Cancer Type: Clear cell

Background:

Stereotactic Radiation Therapy (SRT) is used to treat cancers using substantially higher doses of radiation than conventional radiotherapy, while limiting the dose of radiation to nearby normal tissues. SRT is commonly employed in cancers of the lung, liver, and pancreas, where it is used to shrink tumours that have spread to other parts of the body.

Sunitinib (Sutent®) has been a standard of care treatment for kidney cancer since 2006 and works by blocking a molecule called VEGFR to prevent cancerous tumours from growing new blood vessels.


The Trial:

The purpose of this trial is to explore the safety and effectiveness of SRT for the treatment of kidney cancer among patients already being treated with Sunitinib (Sutent®).

Specifically, this trial will investigate how much longer patients receiving SRT are able to continue receiving Sunitinib before they must switch to a different medication.


Basic Eligibility:

  • Clear cell kidney cancer
  • Receiving Sunitinib for at least 3 months prior to enrollment
  • No more than 5 tumours may be treated with SRT

Additional eligibility criteria will apply. Please speak to your doctor.

 

Find out more about this study.
Hospital / Cancer CentrePrincipal InvestigatorLocationTrial Status
Hospital / Cancer CentreBC Cancer Agency Principal InvestigatorDr Christian Kollmannsberger LocationVancouver, BC Trial StatusRecruiting
Hospital / Cancer CentreTom Baker Cancer Centre Principal InvestigatorDr Gerald Lim LocationCalgary, AB Trial StatusRecruiting
Hospital / Cancer CentreCross Cancer Institute Principal InvestigatorDr Samir Patel LocationEdmonton, AB Trial StatusRecruiting
Hospital / Cancer CentreCancerCare Manitoba Principal InvestigatorDr Arbind Dubey LocationWinnipeg, MB Trial StatusRecruiting
Hospital / Cancer CentreJuravinski Cancer Centre | Hamilton Health Sciences Centre Principal InvestigatorDr Anand Swaminath LocationHamilton, ON Trial StatusRecruiting
Hospital / Cancer CentreLondon Health Sciences Centre Principal InvestigatorDr Belal Ahmad LocationLondon, ON Trial StatusRecruiting
Hospital / Cancer CentreOttawa Hospital Cancer Centre Principal InvestigatorDr Scott Morgan LocationOttawa, ON Trial StatusRecruiting
Hospital / Cancer CentreOdette Cancer Centre | Sunnybrook Health Sciences Centre Principal InvestigatorDr Georg Bjarnason & Dr Patrick Cheung LocationToronto, ON Trial StatusRecruiting
Hospital / Cancer CentrePrincess Margaret Cancer Centre | University Health Network Principal InvestigatorDr Srikala Sridhar LocationToronto, ON Trial StatusRecruiting
Hospital / Cancer CentreHôpital général juif | Jewish General Hospital Principal InvestigatorDr Tamim Niazi LocationMontréal, QC Trial StatusRecruiting
Hospital / Cancer CentreCentre universitaire de santé McGill | McGill University Health Centre Principal InvestigatorDr Fabio Cury LocationMontréal, QC Trial StatusRecruiting
Hospital / Cancer CentreQEII Health Sciences Centre Principal InvestigatorDr Lori Wood LocationHalifax, NS Trial StatusRecruiting
Do NOT follow this link or you will be banned from the site!